1 Department of Medicine.
Am J Respir Crit Care Med. 2014 Mar 15;189(6):707-17. doi: 10.1164/rccm.201311-2047OC.
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder of motile cilia, but the genetic cause is not defined for all patients with PCD.
To identify disease-causing mutations in novel genes, we performed exome sequencing, follow-up characterization, mutation scanning, and genotype-phenotype studies in patients with PCD.
Whole-exome sequencing was performed using NimbleGen capture and Illumina HiSeq sequencing. Sanger-based sequencing was used for mutation scanning, validation, and segregation analysis.
We performed exome sequencing on an affected sib-pair with normal ultrastructure in more than 85% of cilia. A homozygous splice-site mutation was detected in RSPH1 in both siblings; parents were carriers. Screening RSPH1 in 413 unrelated probands, including 325 with PCD and 88 with idiopathic bronchiectasis, revealed biallelic loss-of-function mutations in nine additional probands. Five affected siblings of probands in RSPH1 families harbored the familial mutations. The 16 individuals with RSPH1 mutations had some features of PCD; however, nasal nitric oxide levels were higher than in patients with PCD with other gene mutations (98.3 vs. 20.7 nl/min; P < 0.0003). Additionally, individuals with RSPH1 mutations had a lower prevalence (8 of 16) of neonatal respiratory distress, and later onset of daily wet cough than typical for PCD, and better lung function (FEV1), compared with 75 age- and sex-matched PCD cases (73.0 vs. 61.8, FEV1 % predicted; P = 0.043). Cilia from individuals with RSPH1 mutations had normal beat frequency (6.1 ± Hz at 25°C), but an abnormal, circular beat pattern.
The milder clinical disease and higher nasal nitric oxide in individuals with biallelic mutations in RSPH1 provides evidence of a unique genotype-phenotype relationship in PCD, and suggests that mutations in RSPH1 may be associated with residual ciliary function.
原发性纤毛运动障碍(PCD)是一种由动力纤毛遗传异质性隐性疾病引起的,但并非所有 PCD 患者的遗传原因都已确定。
为了确定新基因的致病突变,我们对 PCD 患者进行了外显子组测序、后续特征分析、突变扫描和基因型-表型研究。
使用 NimbleGen 捕获和 Illumina HiSeq 测序进行全外显子组测序。Sanger 测序用于突变扫描、验证和分离分析。
我们对一对超微结构正常的受影响同胞进行了外显子组测序。在两个同胞中均发现 RSPH1 的纯合剪接位点突变;父母为携带者。在包括 325 名 PCD 患者和 88 名特发性支气管扩张症患者在内的 413 名无关先证者中筛查 RSPH1,发现另外 9 名先证者存在双等位基因功能丧失突变。RSPH1 家系中 16 名受影响的先证者均携带家族性突变。16 名携带 RSPH1 突变的个体具有 PCD 的某些特征;然而,与其他基因突变的 PCD 患者相比,鼻一氧化氮水平更高(98.3 与 20.7 nl/min;P < 0.0003)。此外,与典型 PCD 相比,RSPH1 突变个体的新生儿呼吸窘迫发生率(8 例中的 16 例)和每日湿咳的发病时间较晚,肺功能(FEV1)更好,与 75 名年龄和性别匹配的 PCD 病例相比(73.0 与 61.8,FEV1 %预测值;P = 0.043)。RSPH1 突变个体的纤毛具有正常的拍动频率(25°C 时为 6.1 ± Hz),但具有异常的圆形拍动模式。
RSPH1 双等位基因突变个体的临床疾病较轻,鼻一氧化氮水平较高,这为 PCD 中的独特基因型-表型关系提供了证据,并表明 RSPH1 突变可能与残余纤毛功能有关。